Previously submitted to: JMIR Public Health and Surveillance (no longer under consideration since Apr 01, 2024)
Date Submitted: Oct 10, 2023
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Association of Sleep Duration and Depression with Mortality in Cancer Survivors: Prospective Cohort Study
ABSTRACT
Background:
Sleep problems and depression are common among cancer survivors and there is an urgent need for effective strategies to improve their long-term health and survival. However, evidence of the association between sleep duration, depression, and mortality in cancer survivors is limited.
Objective:
To examine the individual and joint associations of baseline sleep duration and depression with follow-up all-cause, cancer-specific, and non-cancer mortality in a nationally representative US sample of cancer survivors.
Methods:
Participants were involved in the National Health and Nutrition Examination Surveys from 2005 to 2014 and were linked to a mortality database up to 31 December 2019. Sleep duration was self-reported at baseline, whereby participants were asked “How many (hours) did you sleep (<6, 6, 7, 8, or >8 h/day)?” Depression was assessed using the nine-item Patient Health Questionnaire (PHQ-9) and a total score of ≥ 10 is considered clinically relevant depression. The dose-response relationship between sleep duration and mortality was evaluated with a restricted cubic spline. The individual and joint associations between sleep duration, depression, and mortality were investigated using the Cox proportional hazards regression model.
Results:
A total of 699 deaths occurred among 2,111 participants (mean [SE] age, 61.9 [14.5] years; 1129 [57.9%] female) during a median follow-up period of 99 months. A nonlinear relationship between sleep duration and total mortality was found using restricted cubic spline analysis (p < 0.01), with a higher risk of total mortality in both long- and short-sleepers. Compared with those in patients who slept 7 h, positive associations of < 6 h (hazard ratio [HR], 1.87; 95 % confidence interval [CI], 1.32–2.65), 8 h (HR, 1.47; 95 % CI, 1.17–1.85), and > 8 h (HR, 1.55; 95 % CI, 1.13–2.11) durations with all-cause mortality were observed. In the joint analysis, the combination of abnormal sleep duration and depression was associated with total mortality risk. Specifically, cancer survivors with depression had a higher risk of all-cause mortality when sleeping < 6 h (HR, 1.81; 95% CI, 1.17-2.81) or ≥ 8 h (HR, 1.76; 95% CI, 1.16-2.67); while survivors without depression who slept ≥ 8 h also had an increased risk of all-cause mortality (HR, 1.23; 95% CI, 1.03-1.46).
Conclusions:
Excessive (≥ 8 h) and insufficient (< 6 h) sleep duration was both associated with increased risks of all-cause deaths after adjusting for depression scores. We also observed a joint effect of sleep duration and depression. The findings may provide evidence to guide optimal sleep time for prolonged cancer survival.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.